{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:24:44Z","timestamp":1770060284564,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,2]]},"DOI":"10.7759\/cureus.102813","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T09:07:21Z","timestamp":1770023241000},"source":"Crossref","is-referenced-by-count":0,"title":["Pharmacogenetic Considerations in Sertraline Augmentation With Quetiapine in an Adolescent Woman With Obsessive-Compulsive Disorder, Autism Spectrum Disorder, and Attention-Deficit Hyperactivity Disorder: A Case Report"],"prefix":"10.7759","author":[{"given":"Adebusola","family":"Adegbola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil","family":"Dhir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omotola","family":"Ogunjobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"National Institute for Health and Care Excellence. Obsessive-compulsive disorder and body dysmorphic disorder. treatment. Clinical guideline CG31. National Institute for Health and Care Excellence (NICE). (2005). https:\/\/www.nice.org.uk\/guidance\/cg31."},{"key":"ref2","article-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor DM","year":"2021","unstructured":"Taylor DM, Barnes TR, Young AH. The Maudsley Prescribing Guidelines in Psychiatry. John Wiley, New York; 2021."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.69.2.228","article-title":"Homocysteine, folate, methylation, and monoamine metabolism in depression","volume":"69","author":"Bottiglieri T","year":"2000","unstructured":"Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry. 2000, 69:228-32. 10.1136\/jnnp.69.2.228","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2174\/138920008784746373","article-title":"Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions","volume":"9","author":"Urichuk L","year":"2008","unstructured":"Urichuk L, Prior TI, Dursun S, Baker G. Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions. Curr Drug Metab. 2008, 9:410-8. 10.2174\/138920008784746373","journal-title":"Curr Drug Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/aur.108","article-title":"Autism spectrum and obsessive-compulsive disorders: OC behaviors, phenotypes and genetics","volume":"2","author":"Jacob S","year":"2009","unstructured":"Jacob S, Landeros-Weisenberger A, Leckman JF. Autism spectrum and obsessive-compulsive disorders: OC behaviors, phenotypes and genetics. Autism Res. 2009, 2:293-311. 10.1002\/aur.108","journal-title":"Autism Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7610.2008.01948.x","article-title":"Cognitive behavioral therapy for anxiety in children with autism spectrum disorders: a randomized, controlled trial","volume":"50","author":"Wood JJ","year":"2009","unstructured":"Wood JJ, Drahota A, Sze K, Har K, Chiu A, Langer DA. Cognitive behavioral therapy for anxiety in children with autism spectrum disorders: a randomized, controlled trial. J Child Psychol Psychiatry. 2009, 50:224-34. 10.1111\/j.1469-7610.2008.01948.x","journal-title":"J Child Psychol Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2011.0173","article-title":"Obsessive-compulsive disorder in children and adolescents","volume":"108","author":"Walitza S","year":"2011","unstructured":"Walitza S, Melfsen S, Jans T, Zellmann H, Wewetzer C, Warnke A. Obsessive-compulsive disorder in children and adolescents. Dtsch Arztebl Int. 2011, 108:173-9. 10.3238\/arztebl.2011.0173","journal-title":"Dtsch Arztebl Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10567-011-0097-0","article-title":"Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis","volume":"14","author":"van Steensel FJ","year":"2011","unstructured":"van Steensel FJ, B\u00f6gels SM, Perrin S. Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis. Clin Child Fam Psychol Rev. 2011, 14:302-17. 10.1007\/s10567-011-0097-0","journal-title":"Clin Child Fam Psychol Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-024-06357-8","article-title":"Repetitive behaviors in autism and obsessive-compulsive disorder: a systematic review","volume":"55","author":"O'Loghlen J","year":"2025","unstructured":"O'Loghlen J, McKenzie M, Lang C, Paynter J. Repetitive behaviors in autism and obsessive-compulsive disorder: a systematic review. J Autism Dev Disord. 2025, 55:2307-21. 10.1007\/s10803-024-06357-8","journal-title":"J Autism Dev Disord"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.179.4.324","article-title":"Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health","volume":"179","author":"Heyman I","year":"2001","unstructured":"Heyman I, Fombonne E, Simmons H, Ford T, Meltzer H, Goodman R. Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health. Br J Psychiatry. 2001, 179:324-9. 10.1192\/bjp.179.4.324","journal-title":"Br J Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00717","article-title":"Antidepressants in children and adolescents: meta-review of efficacy, tolerability and suicidality in acute treatment","volume":"11","author":"Boaden K","year":"2020","unstructured":"Boaden K, Tomlinson A, Cortese S, Cipriani A. Antidepressants in children and adolescents: meta-review of efficacy, tolerability and suicidality in acute treatment. Front Psychiatry. 2020, 11:717. 10.3389\/fpsyt.2020.00717","journal-title":"Front Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_896_21","article-title":"Are the symptom dimensions a predictor of short-term response to pharmacotherapy in pediatric obsessive-compulsive disorder? A retrospective cohort study","volume":"64","author":"Cifter A","year":"2022","unstructured":"Cifter A, Erdogdu AB. Are the symptom dimensions a predictor of short-term response to pharmacotherapy in pediatric obsessive-compulsive disorder? A retrospective cohort study. Indian J Psychiatry. 2022, 64:395-400. 10.4103\/indianjpsychiatry.indianjpsychiatry_896_21","journal-title":"Indian J Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19ac13182","article-title":"Pharmacotherapy for treatment-resistant obsessive-compulsive disorder","volume":"81","author":"Kayser RR","year":"2020","unstructured":"Kayser RR. Pharmacotherapy for treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2020, 81:19ac13182. 10.4088\/JCP.19ac13182","journal-title":"J Clin Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001823","article-title":"A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder","volume":"11","author":"Bloch MH","year":"2006","unstructured":"Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006, 11:622-32. 10.1038\/sj.mp.4001823","journal-title":"Mol Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv047","article-title":"Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: an update meta-analysis of double-blind, randomized, placebo-controlled trials","volume":"18","author":"Dold M","year":"2015","unstructured":"Dold M, Aigner M, Lanzenberger R, Kasper S. Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: an update meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacol. 2015, 18:pyv047. 10.1093\/ijnp\/pyv047","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/psychiatry.IndianJPsychiatry_519_18","article-title":"Antipsychotic augmentation in the treatment of obsessive-compulsive disorder","volume":"61","author":"Thamby A","year":"2019","unstructured":"Thamby A, Jaisoorya TS. Antipsychotic augmentation in the treatment of obsessive-compulsive disorder. Indian J Psychiatry. 2019, 61:S51-7. 10.4103\/psychiatry.IndianJPsychiatry_519_18","journal-title":"Indian J Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2022.152352","article-title":"Treatment-resistant OCD: pharmacotherapies in adults","volume":"120","author":"van Roessel PJ","year":"2023","unstructured":"van Roessel PJ, Grassi G, Aboujaoude EN, Mench\u00f3n JM, Van Ameringen M, Rodr\u00edguez CI. Treatment-resistant OCD: pharmacotherapies in adults. Compr Psychiatry. 2023, 120:152352. 10.1016\/j.comppsych.2022.152352","journal-title":"Compr Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-5-5","article-title":"Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study (ISRCTN83050762)","volume":"5","author":"Carey PD","year":"2005","unstructured":"Carey PD, Vythilingum B, Seedat S, Muller JE, van Ameringen M, Stein DJ. Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study (ISRCTN83050762). BMC Psychiatry. 2005, 5:5. 10.1186\/1471-244X-5-5","journal-title":"BMC Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v65n0803","article-title":"A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors","volume":"65","author":"Denys D","year":"2004","unstructured":"Denys D, de Geus F, van Megen HJ, Westenberg HG. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry. 2004, 65:1040-8. 10.4088\/jcp.v65n0803","journal-title":"J Clin Psychiatry"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/1362361313512902","article-title":"Access to services, quality of care, and family impact for children with autism, other developmental disabilities, and other mental health conditions","volume":"18","author":"Vohra R","year":"2014","unstructured":"Vohra R, Madhavan S, Sambamoorthi U, St Peter C. Access to services, quality of care, and family impact for children with autism, other developmental disabilities, and other mental health conditions. Autism. 2014, 18:815-26. 10.1177\/1362361313512902","journal-title":"Autism"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/453157-pharmacogenetic-considerations-in-sertraline-augmentation-with-quetiapine-in-an-adolescent-woman-with-obsessive-compulsive-disorder-autism-spectrum-disorder-and-attention-deficit-hyperactivity-disorder-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T09:07:23Z","timestamp":1770023243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/453157-pharmacogenetic-considerations-in-sertraline-augmentation-with-quetiapine-in-an-adolescent-woman-with-obsessive-compulsive-disorder-autism-spectrum-disorder-and-attention-deficit-hyperactivity-disorder-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.102813","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,2]]}}}